CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.
The Journal of clinical investigation 2018 05 14128(6) 2613-2625 doi 10.1172/JCI98769 Abstract Critical immune-suppressive pathways beyond programmed death 1 (PD-1) and programmed death ligand 1 (PD-L1) require greater...
Read More